生产企业：Telix Pharmaceuticals Limited
FET F-18 is under investigation in clinical trial NCT01756352 (FET-PET for Evaluation of Response of Recurrent GBM to Avastin).
FET F-18 is under investigation in clinical trial NCT01756352 (FET-PET for Evaluation of Response of Recurrent GBM to Avastin).
After intravenous administration, floretyrosine F 18 (Pixclara) is taken up via amino acid transport systems, targeting membrane transport proteins known as L-type amino acid transporters 1 and 2 (LAT1 and LAT2); emissions from the fluorine-18 radioisotope are then detected by a PET scanner.
Indicated for use with positron emission tomography (PET) to differentiate recurrent or progressive glioma from treatment-related change, in conjunction with other diagnostic evaluations, in adults and pediatric patients 1 month of age and older.
共 1 项相关疾病
